Experimental study of USPIO-enhanced MRI in the detection of atherosclerotic plaque and the intervention of atorvastatin

Experimental and Therapeutic Medicine

Volumn 12, Issue 1, 2016, Pages 141-146

  Sha, Ting ^a   Qi, Chunmei ^a   Fu, Wei ^a   Hao, Ji ^a   Gong, Lei ^a   Wu, Hao ^a   Zhang, Qingdui ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerotic plaque; Cell adhesion molecule 1; Superparamagnetic iron oxide

Indexed keywords

EID: 84968919481     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2016.3266     Document Type: Article

References (26)

1. Virani SS, Polsani VR and Nambi V: Novel markers of infam-mation in atherosclerosis. Curr Atheroscler Rep 10: 164-170, 2008.
2. Kleemann R, Zadelaar S and Kooistra T: Cytokines and athero-sclerosis: A comprehensive review of studies in mice. Cardiovasc Res 79: 360-376, 2008.
3. Wang HD, Yu SQ, Gao F and Qin ML: The anti-atherosclerosiseffect of adiponectin. Chongqing Med J 38: 2509-2510, 2009 (In Chinese).
4. Pasceri V, Willerson JT and Yeh ET: Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165-2168 2002.
5. Beck B, Weintraub W and Alexander R: Elevation of C-reactive protein in ‘active’ coronary artery disease. AMJ Cardiol 65: 168-172, 1990.
6. Ross R: Atherosclerosis - an infammatory disease. N Engl J Med 340: 115-126, 1999.
7. Tang T, Howarth SP, Miller SR, Trivedi R, Graves MJ, King-Im JU, Li ZY, Brown AP, Kirkpatrick PJ, Gaunt ME, et al: Assessment of infammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 37: 2266-2270, 2006.
8. Howarth SP, Tang TY, Graves MJ, U-King-Im JM, Li ZY, Walsh SR, Gaunt ME and Gillard JH: Non-invasive MR imaging of infammation in a patient with both asymptomatic carotidatheroma and an abdominal aortic aneurysm: A case report. Ann Surg Innov Res 1: 4, 2007.
9. Metz S, Beer AJ, Settles M, Pelisek J, Botnar RM, Rummeny EJ and Heider P: Characterization of carotid artery plaques with USPIO-enhanced MRI: Assessment of infammation and vascu-larity as in vivo imaging biomarkers for plaque vulnerability. Int J Cardiovasc Imaging 27: 901-912, 2011.
10. Truskey GA, Herrmann RA, Kait J and Barber KM: Focalincreases in vascular cell adhesion molecule-1 and intimal macrophages at atherosclerosis-susceptible sites in the rabbit aorta after short-term cholesterol feeding. Arterioscler Thromb Vasc Biol 19: 393-401, 1999.
11. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW and Milstone DS: A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107: 1255-1262, 2001.
12. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, et al: Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349: 2316-2325, 2003.
13. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB and Gudnason V: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350: 1387-1397, 2004.
14. Curb JD, Abbott RD, Rodriguez BL, Sakkinen P, Popper JS, Yano K and Tracy RP: C-reation protein and the future risk of thromboembolic stroke in healthy men. Circulation 107: 2016-2020, 2003.
15. Schupp M, Janke J, Clasen R, Unger T and Kintscher U: Angiotensin type-1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 109: 2054-2057, 2004.
16. Padda RS, Shi Y, Lo CS, Zhang SL and Chan JS: Angiotensin-(1-7): A novel peptide to treat hypertension and nephropathy in diabetes? J Diabetes Metab 6: 1-6, 2015.
17. -/- mice.Am J Physiol Gastrointest Liver Physiol 308: G251-G261, 2015.
18. Kurz KD, Main BW and Sandusky GE: Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 60: 269-280, 1990.
19. Chen WQ, Zhang Y, Zhang M, Ji XP, Yin Y and Zhu YF: Establishing an animal model of unstable atherosclerotic plaques. Chin Med J (Engl) 117: 1293-1298, 2004.
20. Chen WQ, Zhang L, Liu YF, Chen L, Ji XP, Zhang M, Zhao YX, Yao GH, Zhang C, Wang XL, et al: Prediction of atherosclerotic plaque ruptures with high-frequency ultrasound imaging and serum inflammatory markers. Am J Physiol Heart Circ Physiol 293: H2836-H2844, 2007.
21. Cormode DP, Skajaa T, Fayad ZA and Mulder WJ: Nanotechnology in medical imaging: Probe design and applications. Arterioscler Thromb Vasc Biol 29: 992-1000, 2009.
22. Cormode DP, Briley-Saebo KC, Mulder WJ, Aguinaldo JG, Barazza A, Ma Y, Fisher EA and Fayad ZA: An ApoA-Imimetic peptide high-density-lipoprotein-based MRI contrastagent for atherosclerotic plaque composition detection. Small 4: 1437-1444, 2008.
23. Clarke SE, Beletsky V, Hammond RR, Hegele RA and Rutt BK: Validation of automatically classified magnetic resonance images for carotid plaque compositional analysis. Stroke 37: 93-97, 2006.
24. Drakopoulou M, Toutouzas K, Michelongona A, Tousoulis D and Stefanadis C: Vulnerable plaque and inflammation: Potential clinical strategies. Curr Pharm Des 17: 4190-4209, 2011.
25. Li D, Chen H, Romeo F, Sawamura T, Saldeen T and Mehta JL: Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: Role of LOX-1. J Pharmacol Exp Ther 302: 601-605, 2002.
26. Li DY, Chen HJ and Mehta JL: Statins inhibit oxidized-LDL-medated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Cardiovasc Res 52: 130-135, 2001.